Hyloris Pharmaceuticals SA 2024 SR
The report highlights Hyloris Pharmaceuticals' commitment to sustainability through its strategic focus on health, environmental responsibility, and ethical governance. Key achievements include operating from a BREEAM-certified 'Excellent' headquarters and transitioning to a hybrid and electric vehicle fleet to reduce carbon emissions. The company maintains a diverse workforce with 13 nationalities and a nearly balanced gender ratio, though it aims to improve female representation on its Board. Hyloris addresses critical global health issues, such as the opioid crisis and cardiovascular diseases, by leveraging the 505(b)(2) regulatory pathway to provide safer, faster, and more affordable treatments. Furthermore, the report details the company's adherence to the 2020 Belgian Code on Corporate Governance and its efforts to minimize animal testing.
Company: Hyloris Pharmaceuticals SA
Sector: Manufacturing
Country: Belgium
Year: 2024
Type: SR
Pages: 15
Back to company
Hyloris Pharmaceuticals SA
Sustainability Report
The report highlights Hyloris Pharmaceuticals' commitment to sustainability through its strategic focus on health, environmental responsibility, and ethical governance. Key achievements include operating from a BREEAM-certified 'Excellent' headquarters and transitioning to a hybrid and electric vehicle fleet to reduce carbon emissions. The company maintains a diverse workforce with 13 nationalities and a nearly balanced gender ratio, though it aims to improve female representation on its Board. Hyloris addresses critical global health issues, such as the opioid crisis and cardiovascular diseases, by leveraging the 505(b)(2) regulatory pathway to provide safer, faster, and more affordable treatments. Furthermore, the report details the company's adherence to the 2020 Belgian Code on Corporate Governance and its efforts to minimize animal testing.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Workplace Fatalities
Employees